Literature DB >> 1348542

Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation.

M C Fournié-Zaluski1, P Coric, S Turcaud, L Bruetschy, E Lucas, F Noble, B P Roques.   

Abstract

Derivatives of amino acids bearing various zinc-coordinating moieties (SH, COOH, CONHOH, and PO3H2) were synthesized and tested for their ability to inhibit aminopeptidase N (APN). Among them, beta-amino thiols were found to be the most efficient with IC50's in the 11-50 nM range. These results suggest that the S1 subsite of APN is a deep but not very large hydrophobic pocket, optimally fitting side chains of moderate bulk endowed with some degree of freedom. The iv administration of the inhibitors, alone, did not induce antinociceptive responses on the hot plate test in mice. However, in presence of 10 mg/kg acetorphan, a prodrug of the neutral endopeptidase inhibitor thiorphan, these compounds gave a large increase in the jump latency time with ED50's of 2 and 2.4 mg/kg for the disulfides of methioninethiol H2NCH(CH2CH2SCH3)CH2S]2 and S-oxomethioninethiol [H2NCH(CH2CH2S(O)CH3)CH2S]2, respectively. These results show that the disulfide forms of beta-amino thiols are efficient prodrugs of aminopeptidase N inhibitors capable of crossing the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348542     DOI: 10.1021/jm00085a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics.

Authors:  H Chen; F Noble; P Coric; M C Fournie-Zaluski; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

Review 2.  Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future Directions.

Authors:  Mathilde Keck; Reda Hmazzou; Catherine Llorens-Cortes
Journal:  Curr Hypertens Rep       Date:  2019-05-21       Impact factor: 5.369

3.  Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug.

Authors:  Fabrice Balavoine; Michel Azizi; Damien Bergerot; Nadia De Mota; Rémi Patouret; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Clin Pharmacokinet       Date:  2014-04       Impact factor: 6.447

4.  Aminopeptidase A inhibitors as potential central antihypertensive agents.

Authors:  A Reaux; M C Fournie-Zaluski; C David; S Zini; B P Roques; P Corvol; C Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 5.  Role of angiotensin III in hypertension.

Authors:  Annabelle Reaux-Le Goazigo; Xavier Iturrioz; Celine Fassot; Cedric Claperon; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

6.  A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A.

Authors:  G Vazeux; X Iturrioz; P Corvol; C Llorens-Cortes
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

7.  Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors.

Authors:  Marcin Drag; Matthew Bogyo; Jonathan A Ellman; Guy S Salvesen
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

8.  Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.

Authors:  Marie-Claude Fournie-Zaluski; Celine Fassot; Bruno Valentin; Dragan Djordjijevic; Annabelle Reaux-Le Goazigo; Pierre Corvol; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

Review 9.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

10.  Binding properties of a highly potent and selective iodinated aminopeptidase N inhibitor appropriate for radioautography.

Authors:  F Noble; N Luciani; S Da Nascimento; R Laï-Kuen; L Bischoff; H Chen; M C Fournié-Zaluski; B P Roques
Journal:  FEBS Lett       Date:  2000-02-04       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.